Coronary Atherosclerosis in Athletes: Exploring the Role of Sporting Discipline

Vincent L. Aengevaeren; A. Mosterd; Sanjay Sharma; Thijs L. Braber; Paul D. Thompson; Birgitta K. Velthuis; Thijs M.H. Eijsvogels

doi:10.1016/j.jcmg.2019.01.002

Coronary Atherosclerosis in Athletes: Exploring the Role of Sporting Discipline

Vincent L. Aengevaeren, A. Mosterd, Sanjay Sharma, Thijs L. Braber, Paul D. Thompson, Birgitta K. Velthuis, Thijs M.H. Eijsvogels^*

^*Corresponding author for this work

Research output: Contribution to journal › Letter › Academic › peer-review

1 Citation (Scopus)

Original language	English
Pages (from-to)	1587-1589
Number of pages	3
Journal	JACC: Cardiovascular Imaging
Volume	12
Issue number	8
DOIs	https://doi.org/10.1016/j.jcmg.2019.01.002
Publication status	Published - 1 Aug 2019

Access to Document

10.1016/j.jcmg.2019.01.002

Cite this

@article{2e1fcc0bfb194ae88162ea2b891b8a84,

title = "Coronary Atherosclerosis in Athletes: Exploring the Role of Sporting Discipline",

author = "Aengevaeren, {Vincent L.} and A. Mosterd and Sanjay Sharma and Braber, {Thijs L.} and Thompson, {Paul D.} and Velthuis, {Birgitta K.} and Eijsvogels, {Thijs M.H.}",

note = "Funding Information: Please note: This work was supported by a grant from SPORTCOR, a Dutch national registry of sudden cardiac arrest in athletes, the Foundations “Wetenschappelijk Onderzoek Hart-en Vaatziekten” and “Bijstand Meander Medical Center” Amersfoort, the R{\"o}ntgen Foundation Utrecht and Philips Healthcare. Drs. Aengevaeren and Eijsvogels are financially supported by grants from the Dutch Heart Foundation (#2017T088 and #2017T051, respectively). Dr. Thompson has received grant support from Sanofi, Regeneron, Esperion, Amarin, and Amgen; has served as a consultant for Amgen, Regeneron, Sanofi, and Esperion; has received speaker honoraria from Amarin, Sanofi, Regeneron, Amgen, and Kowa; and owns stock in Abbvie, Abbott Labs, CVS, General Electric, Johnson & Johnson, Medtronic, Sarepta, Boston Scientific, and Myokardia. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. Funding Information: Please note: This work was supported by a grant from SPORTCOR, a Dutch national registry of sudden cardiac arrest in athletes, the Foundations “Wetenschappelijk Onderzoek Hart-en Vaatziekten” and “Bijstand Meander Medical Center” Amersfoort, the R{\"o}ntgen Foundation Utrecht and Philips Healthcare. Drs. Aengevaeren and Eijsvogels are financially supported by grants from the Dutch Heart Foundation (#2017T088 and #2017T051, respectively). Dr. Thompson has received grant support from Sanofi, Regeneron, Esperion, Amarin, and Amgen; has served as a consultant for Amgen, Regeneron, Sanofi, and Esperion; has received speaker honoraria from Amarin, Sanofi, Regeneron, Amgen, and Kowa; and owns stock in Abbvie, Abbott Labs, CVS, General Electric, Johnson & Johnson, Medtronic, Sarepta, Boston Scientific, and Myokardia. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.",

year = "2019",

month = aug,

day = "1",

doi = "10.1016/j.jcmg.2019.01.002",

language = "English",

volume = "12",

pages = "1587--1589",

journal = "JACC: Cardiovascular Imaging",

issn = "1936-878X",

publisher = "Elsevier",

number = "8",

}

TY - JOUR

T1 - Coronary Atherosclerosis in Athletes

T2 - Exploring the Role of Sporting Discipline

AU - Aengevaeren, Vincent L.

AU - Mosterd, A.

AU - Sharma, Sanjay

AU - Braber, Thijs L.

AU - Thompson, Paul D.

AU - Velthuis, Birgitta K.

AU - Eijsvogels, Thijs M.H.

N1 - Funding Information: Please note: This work was supported by a grant from SPORTCOR, a Dutch national registry of sudden cardiac arrest in athletes, the Foundations “Wetenschappelijk Onderzoek Hart-en Vaatziekten” and “Bijstand Meander Medical Center” Amersfoort, the Röntgen Foundation Utrecht and Philips Healthcare. Drs. Aengevaeren and Eijsvogels are financially supported by grants from the Dutch Heart Foundation (#2017T088 and #2017T051, respectively). Dr. Thompson has received grant support from Sanofi, Regeneron, Esperion, Amarin, and Amgen; has served as a consultant for Amgen, Regeneron, Sanofi, and Esperion; has received speaker honoraria from Amarin, Sanofi, Regeneron, Amgen, and Kowa; and owns stock in Abbvie, Abbott Labs, CVS, General Electric, Johnson & Johnson, Medtronic, Sarepta, Boston Scientific, and Myokardia. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. Funding Information: Please note: This work was supported by a grant from SPORTCOR, a Dutch national registry of sudden cardiac arrest in athletes, the Foundations “Wetenschappelijk Onderzoek Hart-en Vaatziekten” and “Bijstand Meander Medical Center” Amersfoort, the Röntgen Foundation Utrecht and Philips Healthcare. Drs. Aengevaeren and Eijsvogels are financially supported by grants from the Dutch Heart Foundation (#2017T088 and #2017T051, respectively). Dr. Thompson has received grant support from Sanofi, Regeneron, Esperion, Amarin, and Amgen; has served as a consultant for Amgen, Regeneron, Sanofi, and Esperion; has received speaker honoraria from Amarin, Sanofi, Regeneron, Amgen, and Kowa; and owns stock in Abbvie, Abbott Labs, CVS, General Electric, Johnson & Johnson, Medtronic, Sarepta, Boston Scientific, and Myokardia. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

PY - 2019/8/1

Y1 - 2019/8/1

UR - http://www.scopus.com/inward/record.url?scp=85069857551&partnerID=8YFLogxK

U2 - 10.1016/j.jcmg.2019.01.002

DO - 10.1016/j.jcmg.2019.01.002

M3 - Letter

C2 - 30772217

AN - SCOPUS:85069857551

SN - 1936-878X

VL - 12

SP - 1587

EP - 1589

JO - JACC: Cardiovascular Imaging

JF - JACC: Cardiovascular Imaging

IS - 8

ER -

Coronary Atherosclerosis in Athletes: Exploring the Role of Sporting Discipline

Access to Document

Other files and links

Cite this